Trial intelligence / Profile preview

COHIN: Community health workers addressing oral health in Nouna

PACTR202508745984315Not yet recruiting

Sponsor
Heidelberg Institute of Global Health
Start
Sep 2025
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of silver diamine fluoride in carious lesion and Maxillofacial Disorders (3 arms), sponsored by Heidelberg Institute of Global Health. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

silver diamine fluoride
03

Conditions

carious lesionMaxillofacial Disorders

Beyond the preview

Go deeper on PACTR202508745984315.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202508745984315.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call